SlideShare ist ein Scribd-Unternehmen logo
1 von 15
Downloaden Sie, um offline zu lesen
CA CERVIX
KISOMORO HC III-KABAROLE DISTRICT
Leadership and community placement June 201502/11/15
1Prepared by: Otim Geoffrey BMLS-Mbarara University +256 777 777 800
Incidence /Prevalence /Mortality:
 Worldwide, every two minutes, a woman dies of cervical cancer
 There were an estimated 266,000 global deaths from cervical cancer in
2012,
accounting for 7.5% of all female cancer deaths. Almost nine out of ten
(87%)
cervical cancer deaths occur in less developed regions.
 About 527,624 new cervical cancercases are diagnosed annually in the
World (estimations for2012).
 About 3,915 new cervical cancer cases are diagnosed annually in Uganda
(estimations for 2012).
 Cervical cancer ranks as the 1st cause of female cancer in Uganda.
 Cervical cancer is the 1st most common female cancer in women aged 15
to 44 years in Uganda.
02/11/15
2
Prepared by: Otim Geoffrey BMLS-Mbarara University +256 777 777 800
Reasons forthe higherincidence and mortality in
developing countries
 lack of awareness of cervical cancer among the population,
health care providers and policy-makers;
 absence or poor quality of screening programmes for precursor
lesions and early-stage cancer.
 In women who have never been screened, cancer tends to be
diagnosed in its later stages, when it is less easily treatable
 limited access to health care services
 lack of functional referral systems.
02/11/15
3
Prepared by: Otim Geoffrey BMLS-Mbarara University +256 777 777 800
Cause
 Caused by Human Papilloma Virus
 Transmission is through skin to skin contact and sexual contact
– vagina & anal sex
02/11/15
4
Prepared by: Otim Geoffrey BMLS-Mbarara University +256 777 777 800
Riskfactors
 Tobacco smoking,
 long-term hormonal contraceptive use(Oral contraceptives),
 Early onset of sexual activity – compared with age at first
intercourse of 21 years or older, the risk is approximately 1.5-
fold for 18 to 20 years and two-fold for younger than 18 years
 Multiple sexual partners – compared with one partner, the risk
is approximately two-fold with two partners and three-fold with
6 or more partners
 A high-risk sexual partner (e.g., a partner with multiple sexual
partners or known human papillomavirus infection)
02/11/15
5
Prepared by: Otim Geoffrey BMLS-Mbarara University +256 777 777 800
Riskfactors Cont’d
 Immunosuppression (e.g., human immunodeficiency virus infection),
women HIV positive.
 Uncircumcised sexual partner
 Early age at first birth (younger than 20 years old) and increasing
parity (3 or more full term births)
 Familial History(Sister or mother)
 High number of live childbirth/high fertility rate
 History of sexually transmitted infections (e.g., Chlamydia
trachomatis, genital herpes)
 History of vulvar or vaginal squamous intraepithelial neoplasia or
cancer (HPV infection is also the etiology of most cases of these
conditions)
02/11/15
6
Prepared by: Otim Geoffrey BMLS-Mbarara University +256 777 777 800
Clinical Presentation
 Early cervical cancer is frequently asymptomatic, underscoring
the importance of screening.
 Irregular or heavy vaginal bleeding
 Pain during sexual intercourse
 Post coital bleeding
 vaginal discharge that may be watery, mucoid, or purulent and
malodorous
 Advanced disease may present with pelvic or lower back pain,
hematuria, hematochezia, or vaginal passage of urine or stool
02/11/15
7
Prepared by: Otim Geoffrey BMLS-Mbarara University +256 777 777 800
Complications
 Infertility
 Dissemination to other organs.
02/11/15
8
Prepared by: Otim Geoffrey BMLS-Mbarara University +256 777 777 800
Tests forCa Cervix
 VIA (Visual inspection using acetic acid)
 Pap Smear
 Biopsy
 HPV DNA Testing
 Others
02/11/15
9
Prepared by: Otim Geoffrey BMLS-Mbarara University +256 777 777 800
Screening
The following groups of women should be offered screening:
Any woman between the ages of 15 and 50 years, who has never
had a Pap smear before or who had one 3 or more years ago (or
according to national guidelines).
3 years after a woman begins having vaginal intercourse
 Women whose previous Pap smear was reported as inadequate or
showed a mild abnormality.
Women who have abnormal bleeding, bleeding after intercourse or
after the menopause, or other abnormal symptoms.
Women who have been found to have abnormalities on their cervix.
02/11/15
10
Prepared by: Otim Geoffrey BMLS-Mbarara University +256 777 777 800
Screening Cont’d
 Until age 30, cervical screening should be carried out every
year.
 At or after age 30, a woman who has had three normal
 Test results in a row may be screened every 2 to 3 years with a
Pap test
 A woman 70 years of age and older who has had three or
more normal Pap test results and no abnormal results in the
previous 10 years may choose to stop cervical cancer
screening. 02/11/15
11
Prepared by: Otim Geoffrey BMLS-Mbarara University +256 777 777 800
Patient instructions
 Schedule the examination 2 weeks after the first day of the last
menstrual period. (It is preferable to avoid examination during
menses because blood may obscure significant findings.)
 Do not use vaginal medication, vaginal contraceptives, or
douches for 48 hours before the appointment.
 Intercourse is not recommended the night before the
appointment
02/11/15
12
Prepared by: Otim Geoffrey BMLS-Mbarara University +256 777 777 800
Prevention
 Avoid the risk factors mentioned above
 Vaccination with HPV Vaccine before initial sexual intercourse
 Effective screening and treatment of precancerous lesions
02/11/15
13
Prepared by: Otim Geoffrey BMLS-Mbarara University +256 777 777 800
Treatment
 Cryotherapy
 Surgery e.g. radical or partial hysterectomy
 Radiation therapy 
 Chemotherapy 
02/11/15
14
Prepared by: Otim Geoffrey BMLS-Mbarara University +256 777 777 800
Thanks for Actively listening.
02/11/15
15
Prepared by: Otim Geoffrey BMLS-Mbarara University +256 777 777 800

Weitere ähnliche Inhalte

Was ist angesagt?

cervical cancer presentation
cervical cancer presentation cervical cancer presentation
cervical cancer presentation alaaag
 
Cervical cancer screening guidelines 2013 on 7th sept
Cervical cancer screening guidelines 2013 on 7th septCervical cancer screening guidelines 2013 on 7th sept
Cervical cancer screening guidelines 2013 on 7th septLifecare Centre
 
Cervical cancer
Cervical cancerCervical cancer
Cervical cancermadurai
 
Cervical Cancer Screening - HPV - www.jinekolojivegebelik.com
Cervical Cancer Screening - HPV - www.jinekolojivegebelik.comCervical Cancer Screening - HPV - www.jinekolojivegebelik.com
Cervical Cancer Screening - HPV - www.jinekolojivegebelik.comjinekolojivegebelik.com
 
Panel Discussion on Post Menopausal Bleeding
Panel Discussion on Post Menopausal Bleeding Panel Discussion on Post Menopausal Bleeding
Panel Discussion on Post Menopausal Bleeding Lifecare Centre
 
Cervical Cancer Screening
Cervical Cancer ScreeningCervical Cancer Screening
Cervical Cancer Screeningsarahmccorm
 
HPV Diseases More Than Cervical Cancer, Dr. Sharda Jain
HPV Diseases More Than Cervical Cancer, Dr. Sharda Jain HPV Diseases More Than Cervical Cancer, Dr. Sharda Jain
HPV Diseases More Than Cervical Cancer, Dr. Sharda Jain Lifecare Centre
 
Cervical cancer screening module 1
Cervical cancer screening module 1Cervical cancer screening module 1
Cervical cancer screening module 1MMSCME
 
Cervical Cancer Prevention UPDATE ON H.P.V. vaccination
Cervical Cancer Prevention UPDATE ON H.P.V. vaccinationCervical Cancer Prevention UPDATE ON H.P.V. vaccination
Cervical Cancer Prevention UPDATE ON H.P.V. vaccinationNavneet Upadhyay
 
Fertility Preservation for Gynecologic Cancer Patients
Fertility Preservation for Gynecologic Cancer PatientsFertility Preservation for Gynecologic Cancer Patients
Fertility Preservation for Gynecologic Cancer PatientsJibran Mohsin
 

Was ist angesagt? (20)

cervical cancer presentation
cervical cancer presentation cervical cancer presentation
cervical cancer presentation
 
Cervical Cancer
Cervical CancerCervical Cancer
Cervical Cancer
 
Cervical cancer
Cervical cancerCervical cancer
Cervical cancer
 
Cervical cancer screening in rural india
Cervical cancer screening in rural indiaCervical cancer screening in rural india
Cervical cancer screening in rural india
 
Cervical cancer screening guidelines 2013 on 7th sept
Cervical cancer screening guidelines 2013 on 7th septCervical cancer screening guidelines 2013 on 7th sept
Cervical cancer screening guidelines 2013 on 7th sept
 
Cervical cancer
Cervical cancerCervical cancer
Cervical cancer
 
An overview of cin
An overview of cinAn overview of cin
An overview of cin
 
Cervical Cancer Screening - HPV - www.jinekolojivegebelik.com
Cervical Cancer Screening - HPV - www.jinekolojivegebelik.comCervical Cancer Screening - HPV - www.jinekolojivegebelik.com
Cervical Cancer Screening - HPV - www.jinekolojivegebelik.com
 
Panel Discussion on Post Menopausal Bleeding
Panel Discussion on Post Menopausal Bleeding Panel Discussion on Post Menopausal Bleeding
Panel Discussion on Post Menopausal Bleeding
 
Cervical Cancer Screening
Cervical Cancer ScreeningCervical Cancer Screening
Cervical Cancer Screening
 
Cervical cancer hpv
Cervical cancer hpvCervical cancer hpv
Cervical cancer hpv
 
Cervical cancer
Cervical cancerCervical cancer
Cervical cancer
 
HPV Diseases More Than Cervical Cancer, Dr. Sharda Jain
HPV Diseases More Than Cervical Cancer, Dr. Sharda Jain HPV Diseases More Than Cervical Cancer, Dr. Sharda Jain
HPV Diseases More Than Cervical Cancer, Dr. Sharda Jain
 
Recurrent Pregnancy Loss
Recurrent Pregnancy LossRecurrent Pregnancy Loss
Recurrent Pregnancy Loss
 
Cervical cancer screening module 1
Cervical cancer screening module 1Cervical cancer screening module 1
Cervical cancer screening module 1
 
Cervical cancer
Cervical cancerCervical cancer
Cervical cancer
 
Cervical Cancer
Cervical CancerCervical Cancer
Cervical Cancer
 
Endometrial cancer recommendations
Endometrial cancer recommendationsEndometrial cancer recommendations
Endometrial cancer recommendations
 
Cervical Cancer Prevention UPDATE ON H.P.V. vaccination
Cervical Cancer Prevention UPDATE ON H.P.V. vaccinationCervical Cancer Prevention UPDATE ON H.P.V. vaccination
Cervical Cancer Prevention UPDATE ON H.P.V. vaccination
 
Fertility Preservation for Gynecologic Cancer Patients
Fertility Preservation for Gynecologic Cancer PatientsFertility Preservation for Gynecologic Cancer Patients
Fertility Preservation for Gynecologic Cancer Patients
 

Andere mochten auch

CERVICAL CARCINOMA The Role of the Human Papilloma Virus and Prospects for Pr...
CERVICAL CARCINOMA The Role of the Human Papilloma Virus and Prospects for Pr...CERVICAL CARCINOMA The Role of the Human Papilloma Virus and Prospects for Pr...
CERVICAL CARCINOMA The Role of the Human Papilloma Virus and Prospects for Pr...Alberto Cuadrado
 
HPV Vaccination & Ca. Cervix Screening Update Dr. Sharda Jain Dr. Jyoti A...
HPV Vaccination & Ca. Cervix Screening Update  Dr. Sharda Jain Dr. Jyoti A...HPV Vaccination & Ca. Cervix Screening Update  Dr. Sharda Jain Dr. Jyoti A...
HPV Vaccination & Ca. Cervix Screening Update Dr. Sharda Jain Dr. Jyoti A...Lifecare Centre
 
Ca Cervix Dr Naresh Jakhotia
Ca Cervix Dr Naresh JakhotiaCa Cervix Dr Naresh Jakhotia
Ca Cervix Dr Naresh Jakhotiadrnareshjakhotia
 
Imaging in diagnosis and treatment of carcinoma cervix
Imaging in diagnosis and treatment of carcinoma cervixImaging in diagnosis and treatment of carcinoma cervix
Imaging in diagnosis and treatment of carcinoma cervixJagadesan Pandjatcharam
 
Ca cervix evaluation and staging
Ca cervix evaluation and stagingCa cervix evaluation and staging
Ca cervix evaluation and stagingAnkur Shah
 
Management Of Early Stage Ca Cervix [Autosaved]
Management Of Early Stage Ca Cervix [Autosaved]Management Of Early Stage Ca Cervix [Autosaved]
Management Of Early Stage Ca Cervix [Autosaved]PGIMER, AIIMS
 
Management of Early Stage Carcinoma Cervix
Management of Early Stage Carcinoma CervixManagement of Early Stage Carcinoma Cervix
Management of Early Stage Carcinoma CervixSubhash Thakur
 
Pathology of cervix &uterus
Pathology of cervix &uterusPathology of cervix &uterus
Pathology of cervix &uterusayeayetun08
 
Carcinoma Cervix
Carcinoma CervixCarcinoma Cervix
Carcinoma Cervixdrmcbansal
 
Cervical Cancer Symptoms, Causes, Treatments
Cervical Cancer Symptoms, Causes, TreatmentsCervical Cancer Symptoms, Causes, Treatments
Cervical Cancer Symptoms, Causes, TreatmentsMedWorld India
 
Basic gynae ultrasound
Basic gynae ultrasoundBasic gynae ultrasound
Basic gynae ultrasoundobsgynhsnz
 
CA CERVIX - PUBLIC AWARENESS
CA CERVIX - PUBLIC AWARENESSCA CERVIX - PUBLIC AWARENESS
CA CERVIX - PUBLIC AWARENESSDrAnkitaPatel
 
Ca cervix—standards of care
Ca cervix—standards of careCa cervix—standards of care
Ca cervix—standards of careDrAnkitaPatel
 
Obstetrical Ultrasound
Obstetrical UltrasoundObstetrical Ultrasound
Obstetrical UltrasoundLa Lura White
 
Cancer epidemiology
Cancer epidemiologyCancer epidemiology
Cancer epidemiologyNayyar Kazmi
 

Andere mochten auch (20)

CERVICAL CARCINOMA The Role of the Human Papilloma Virus and Prospects for Pr...
CERVICAL CARCINOMA The Role of the Human Papilloma Virus and Prospects for Pr...CERVICAL CARCINOMA The Role of the Human Papilloma Virus and Prospects for Pr...
CERVICAL CARCINOMA The Role of the Human Papilloma Virus and Prospects for Pr...
 
Ca cervix
Ca cervixCa cervix
Ca cervix
 
HPV and Cervical Cancer Screening
HPV and Cervical Cancer ScreeningHPV and Cervical Cancer Screening
HPV and Cervical Cancer Screening
 
HPV Vaccination & Ca. Cervix Screening Update Dr. Sharda Jain Dr. Jyoti A...
HPV Vaccination & Ca. Cervix Screening Update  Dr. Sharda Jain Dr. Jyoti A...HPV Vaccination & Ca. Cervix Screening Update  Dr. Sharda Jain Dr. Jyoti A...
HPV Vaccination & Ca. Cervix Screening Update Dr. Sharda Jain Dr. Jyoti A...
 
Ca Cervix Dr Naresh Jakhotia
Ca Cervix Dr Naresh JakhotiaCa Cervix Dr Naresh Jakhotia
Ca Cervix Dr Naresh Jakhotia
 
Imaging in diagnosis and treatment of carcinoma cervix
Imaging in diagnosis and treatment of carcinoma cervixImaging in diagnosis and treatment of carcinoma cervix
Imaging in diagnosis and treatment of carcinoma cervix
 
Ca cervix evaluation and staging
Ca cervix evaluation and stagingCa cervix evaluation and staging
Ca cervix evaluation and staging
 
Management Of Early Stage Ca Cervix [Autosaved]
Management Of Early Stage Ca Cervix [Autosaved]Management Of Early Stage Ca Cervix [Autosaved]
Management Of Early Stage Ca Cervix [Autosaved]
 
Management of ca cervix
Management of ca cervixManagement of ca cervix
Management of ca cervix
 
Management of Early Stage Carcinoma Cervix
Management of Early Stage Carcinoma CervixManagement of Early Stage Carcinoma Cervix
Management of Early Stage Carcinoma Cervix
 
Pathology of cervix &uterus
Pathology of cervix &uterusPathology of cervix &uterus
Pathology of cervix &uterus
 
Carcinoma Cervix
Carcinoma CervixCarcinoma Cervix
Carcinoma Cervix
 
Cervical Cancer Symptoms, Causes, Treatments
Cervical Cancer Symptoms, Causes, TreatmentsCervical Cancer Symptoms, Causes, Treatments
Cervical Cancer Symptoms, Causes, Treatments
 
Basic gynae ultrasound
Basic gynae ultrasoundBasic gynae ultrasound
Basic gynae ultrasound
 
CA CERVIX - PUBLIC AWARENESS
CA CERVIX - PUBLIC AWARENESSCA CERVIX - PUBLIC AWARENESS
CA CERVIX - PUBLIC AWARENESS
 
Ca cervix—standards of care
Ca cervix—standards of careCa cervix—standards of care
Ca cervix—standards of care
 
Obstetrical Ultrasound
Obstetrical UltrasoundObstetrical Ultrasound
Obstetrical Ultrasound
 
Radiation for Cervix Cancer
Radiation for Cervix CancerRadiation for Cervix Cancer
Radiation for Cervix Cancer
 
Cancer epidemiology
Cancer epidemiologyCancer epidemiology
Cancer epidemiology
 
Cevical cancer
Cevical cancerCevical cancer
Cevical cancer
 

Ähnlich wie A glance at ca cervix

Article on Cervical cancer.Daily News
Article on Cervical cancer.Daily NewsArticle on Cervical cancer.Daily News
Article on Cervical cancer.Daily NewsShantha Hettiarachchi
 
HPV &Amp; Cervical Cancer Essay
HPV &Amp; Cervical Cancer EssayHPV &Amp; Cervical Cancer Essay
HPV &Amp; Cervical Cancer EssayJennifer Cruz
 
Cervical cancer
Cervical cancerCervical cancer
Cervical cancerdrizsyed
 
Gynaecology cancer awareness
Gynaecology cancer awarenessGynaecology cancer awareness
Gynaecology cancer awarenesslimgengyan
 
Gynaecology cancer awareness
Gynaecology cancer awarenessGynaecology cancer awareness
Gynaecology cancer awarenesslimgengyan
 
Gynaecology cancer awareness
Gynaecology cancer awarenessGynaecology cancer awareness
Gynaecology cancer awarenesschaimingcheng
 
Dr Ayman Ewies - Cervical screening 2009
Dr Ayman Ewies - Cervical screening 2009Dr Ayman Ewies - Cervical screening 2009
Dr Ayman Ewies - Cervical screening 2009AymanEwies
 
Pap smear test
Pap smear testPap smear test
Pap smear testiangould64
 
Hpv Vs Cervical Cancer
Hpv Vs Cervical CancerHpv Vs Cervical Cancer
Hpv Vs Cervical CancerAbby Johnson
 
Respond to each student with 200 words and include a.docx
Respond to each student with 200 words and include a.docxRespond to each student with 200 words and include a.docx
Respond to each student with 200 words and include a.docxwrite4
 
Management and prevention of cervical cancer.pptx
Management and prevention of cervical cancer.pptxManagement and prevention of cervical cancer.pptx
Management and prevention of cervical cancer.pptxAmin Badamosi
 
Health conditions_cervical_cancer_facts
 Health conditions_cervical_cancer_facts Health conditions_cervical_cancer_facts
Health conditions_cervical_cancer_factsgregoriop
 
obstetric and gynaecological management with breast cancer .pptx
obstetric and gynaecological management with breast cancer .pptxobstetric and gynaecological management with breast cancer .pptx
obstetric and gynaecological management with breast cancer .pptxWafaa Benjamin
 
B agusala womens health final
B agusala womens health finalB agusala womens health final
B agusala womens health finalkatejohnpunag
 
Taking A Look At Cervical Cancer
Taking A Look At Cervical CancerTaking A Look At Cervical Cancer
Taking A Look At Cervical CancerChristina Ramirez
 
The incidence of significant lesions on cervical poster
The incidence of significant lesions on cervical   posterThe incidence of significant lesions on cervical   poster
The incidence of significant lesions on cervical posterGenevieve Warner Learmonth
 
Cervical Cancer Educational Presentation
Cervical Cancer Educational PresentationCervical Cancer Educational Presentation
Cervical Cancer Educational Presentationrinki singh
 

Ähnlich wie A glance at ca cervix (20)

Article on Cervical cancer.Daily News
Article on Cervical cancer.Daily NewsArticle on Cervical cancer.Daily News
Article on Cervical cancer.Daily News
 
HPV &Amp; Cervical Cancer Essay
HPV &Amp; Cervical Cancer EssayHPV &Amp; Cervical Cancer Essay
HPV &Amp; Cervical Cancer Essay
 
Cervical cancer
Cervical cancerCervical cancer
Cervical cancer
 
Gynaecology cancer awareness
Gynaecology cancer awarenessGynaecology cancer awareness
Gynaecology cancer awareness
 
Gynaecology cancer awareness
Gynaecology cancer awarenessGynaecology cancer awareness
Gynaecology cancer awareness
 
Gynaecology cancer awareness
Gynaecology cancer awarenessGynaecology cancer awareness
Gynaecology cancer awareness
 
Dr Ayman Ewies - Cervical screening 2009
Dr Ayman Ewies - Cervical screening 2009Dr Ayman Ewies - Cervical screening 2009
Dr Ayman Ewies - Cervical screening 2009
 
Pap smear test
Pap smear testPap smear test
Pap smear test
 
Hpv Vs Cervical Cancer
Hpv Vs Cervical CancerHpv Vs Cervical Cancer
Hpv Vs Cervical Cancer
 
Respond to each student with 200 words and include a.docx
Respond to each student with 200 words and include a.docxRespond to each student with 200 words and include a.docx
Respond to each student with 200 words and include a.docx
 
Management and prevention of cervical cancer.pptx
Management and prevention of cervical cancer.pptxManagement and prevention of cervical cancer.pptx
Management and prevention of cervical cancer.pptx
 
Health conditions_cervical_cancer_facts
 Health conditions_cervical_cancer_facts Health conditions_cervical_cancer_facts
Health conditions_cervical_cancer_facts
 
Cervical cancer bronchure
Cervical cancer bronchureCervical cancer bronchure
Cervical cancer bronchure
 
obstetric and gynaecological management with breast cancer .pptx
obstetric and gynaecological management with breast cancer .pptxobstetric and gynaecological management with breast cancer .pptx
obstetric and gynaecological management with breast cancer .pptx
 
B agusala womens health final
B agusala womens health finalB agusala womens health final
B agusala womens health final
 
Taking A Look At Cervical Cancer
Taking A Look At Cervical CancerTaking A Look At Cervical Cancer
Taking A Look At Cervical Cancer
 
Cervical Cancer
Cervical CancerCervical Cancer
Cervical Cancer
 
Cervical cancer
Cervical cancerCervical cancer
Cervical cancer
 
The incidence of significant lesions on cervical poster
The incidence of significant lesions on cervical   posterThe incidence of significant lesions on cervical   poster
The incidence of significant lesions on cervical poster
 
Cervical Cancer Educational Presentation
Cervical Cancer Educational PresentationCervical Cancer Educational Presentation
Cervical Cancer Educational Presentation
 

Kürzlich hochgeladen

Male Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy DasguptaMale Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy DasguptaSujoy Dasgupta
 
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdfCONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdfDolisha Warbi
 
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxBreast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxNaveenkumar267201
 
Transport across cell membrane (passive, active, vesicular)
Transport across cell membrane (passive, active, vesicular)Transport across cell membrane (passive, active, vesicular)
Transport across cell membrane (passive, active, vesicular)MedicoseAcademics
 
EXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung functionEXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung functionkrishnareddy157915
 
Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.kishan singh tomar
 
Female Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyFemale Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyMedicoseAcademics
 
A presentation on Thermal gravimetry analysis (TGA)
A presentation on Thermal gravimetry analysis (TGA)A presentation on Thermal gravimetry analysis (TGA)
A presentation on Thermal gravimetry analysis (TGA)1922Jaygohel
 
High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)kishan singh tomar
 
Adenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisAdenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisSujoy Dasgupta
 
BENIGN BREAST DISEASE
BENIGN BREAST DISEASE BENIGN BREAST DISEASE
BENIGN BREAST DISEASE Mamatha Lakka
 
Basic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxBasic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxkomalt2001
 
pA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologypA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologyDeepakDaniel9
 
Cure of patients which terminally ill.pdf
Cure of patients which terminally ill.pdfCure of patients which terminally ill.pdf
Cure of patients which terminally ill.pdfrg0000009
 
Forensic Nursing powerpoint presentation
Forensic Nursing powerpoint presentationForensic Nursing powerpoint presentation
Forensic Nursing powerpoint presentationKavitha Krishnan
 
Male Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondMale Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondSujoy Dasgupta
 
Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Vaikunthan Rajaratnam
 
ayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptPradnya Wadekar
 
Role of Soap based and synthetic or syndets bar
Role of  Soap based and synthetic or syndets barRole of  Soap based and synthetic or syndets bar
Role of Soap based and synthetic or syndets barmohitRahangdale
 

Kürzlich hochgeladen (20)

Male Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy DasguptaMale Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy Dasgupta
 
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdfCONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
 
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxBreast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
 
Transport across cell membrane (passive, active, vesicular)
Transport across cell membrane (passive, active, vesicular)Transport across cell membrane (passive, active, vesicular)
Transport across cell membrane (passive, active, vesicular)
 
EXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung functionEXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung function
 
Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.
 
Female Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyFemale Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before Pregnancy
 
A presentation on Thermal gravimetry analysis (TGA)
A presentation on Thermal gravimetry analysis (TGA)A presentation on Thermal gravimetry analysis (TGA)
A presentation on Thermal gravimetry analysis (TGA)
 
High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)
 
Adenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisAdenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosis
 
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
 
BENIGN BREAST DISEASE
BENIGN BREAST DISEASE BENIGN BREAST DISEASE
BENIGN BREAST DISEASE
 
Basic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxBasic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptx
 
pA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologypA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacology
 
Cure of patients which terminally ill.pdf
Cure of patients which terminally ill.pdfCure of patients which terminally ill.pdf
Cure of patients which terminally ill.pdf
 
Forensic Nursing powerpoint presentation
Forensic Nursing powerpoint presentationForensic Nursing powerpoint presentation
Forensic Nursing powerpoint presentation
 
Male Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondMale Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and Beyond
 
Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.
 
ayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologyppt
 
Role of Soap based and synthetic or syndets bar
Role of  Soap based and synthetic or syndets barRole of  Soap based and synthetic or syndets bar
Role of Soap based and synthetic or syndets bar
 

A glance at ca cervix

  • 1. CA CERVIX KISOMORO HC III-KABAROLE DISTRICT Leadership and community placement June 201502/11/15 1Prepared by: Otim Geoffrey BMLS-Mbarara University +256 777 777 800
  • 2. Incidence /Prevalence /Mortality:  Worldwide, every two minutes, a woman dies of cervical cancer  There were an estimated 266,000 global deaths from cervical cancer in 2012, accounting for 7.5% of all female cancer deaths. Almost nine out of ten (87%) cervical cancer deaths occur in less developed regions.  About 527,624 new cervical cancercases are diagnosed annually in the World (estimations for2012).  About 3,915 new cervical cancer cases are diagnosed annually in Uganda (estimations for 2012).  Cervical cancer ranks as the 1st cause of female cancer in Uganda.  Cervical cancer is the 1st most common female cancer in women aged 15 to 44 years in Uganda. 02/11/15 2 Prepared by: Otim Geoffrey BMLS-Mbarara University +256 777 777 800
  • 3. Reasons forthe higherincidence and mortality in developing countries  lack of awareness of cervical cancer among the population, health care providers and policy-makers;  absence or poor quality of screening programmes for precursor lesions and early-stage cancer.  In women who have never been screened, cancer tends to be diagnosed in its later stages, when it is less easily treatable  limited access to health care services  lack of functional referral systems. 02/11/15 3 Prepared by: Otim Geoffrey BMLS-Mbarara University +256 777 777 800
  • 4. Cause  Caused by Human Papilloma Virus  Transmission is through skin to skin contact and sexual contact – vagina & anal sex 02/11/15 4 Prepared by: Otim Geoffrey BMLS-Mbarara University +256 777 777 800
  • 5. Riskfactors  Tobacco smoking,  long-term hormonal contraceptive use(Oral contraceptives),  Early onset of sexual activity – compared with age at first intercourse of 21 years or older, the risk is approximately 1.5- fold for 18 to 20 years and two-fold for younger than 18 years  Multiple sexual partners – compared with one partner, the risk is approximately two-fold with two partners and three-fold with 6 or more partners  A high-risk sexual partner (e.g., a partner with multiple sexual partners or known human papillomavirus infection) 02/11/15 5 Prepared by: Otim Geoffrey BMLS-Mbarara University +256 777 777 800
  • 6. Riskfactors Cont’d  Immunosuppression (e.g., human immunodeficiency virus infection), women HIV positive.  Uncircumcised sexual partner  Early age at first birth (younger than 20 years old) and increasing parity (3 or more full term births)  Familial History(Sister or mother)  High number of live childbirth/high fertility rate  History of sexually transmitted infections (e.g., Chlamydia trachomatis, genital herpes)  History of vulvar or vaginal squamous intraepithelial neoplasia or cancer (HPV infection is also the etiology of most cases of these conditions) 02/11/15 6 Prepared by: Otim Geoffrey BMLS-Mbarara University +256 777 777 800
  • 7. Clinical Presentation  Early cervical cancer is frequently asymptomatic, underscoring the importance of screening.  Irregular or heavy vaginal bleeding  Pain during sexual intercourse  Post coital bleeding  vaginal discharge that may be watery, mucoid, or purulent and malodorous  Advanced disease may present with pelvic or lower back pain, hematuria, hematochezia, or vaginal passage of urine or stool 02/11/15 7 Prepared by: Otim Geoffrey BMLS-Mbarara University +256 777 777 800
  • 8. Complications  Infertility  Dissemination to other organs. 02/11/15 8 Prepared by: Otim Geoffrey BMLS-Mbarara University +256 777 777 800
  • 9. Tests forCa Cervix  VIA (Visual inspection using acetic acid)  Pap Smear  Biopsy  HPV DNA Testing  Others 02/11/15 9 Prepared by: Otim Geoffrey BMLS-Mbarara University +256 777 777 800
  • 10. Screening The following groups of women should be offered screening: Any woman between the ages of 15 and 50 years, who has never had a Pap smear before or who had one 3 or more years ago (or according to national guidelines). 3 years after a woman begins having vaginal intercourse  Women whose previous Pap smear was reported as inadequate or showed a mild abnormality. Women who have abnormal bleeding, bleeding after intercourse or after the menopause, or other abnormal symptoms. Women who have been found to have abnormalities on their cervix. 02/11/15 10 Prepared by: Otim Geoffrey BMLS-Mbarara University +256 777 777 800
  • 11. Screening Cont’d  Until age 30, cervical screening should be carried out every year.  At or after age 30, a woman who has had three normal  Test results in a row may be screened every 2 to 3 years with a Pap test  A woman 70 years of age and older who has had three or more normal Pap test results and no abnormal results in the previous 10 years may choose to stop cervical cancer screening. 02/11/15 11 Prepared by: Otim Geoffrey BMLS-Mbarara University +256 777 777 800
  • 12. Patient instructions  Schedule the examination 2 weeks after the first day of the last menstrual period. (It is preferable to avoid examination during menses because blood may obscure significant findings.)  Do not use vaginal medication, vaginal contraceptives, or douches for 48 hours before the appointment.  Intercourse is not recommended the night before the appointment 02/11/15 12 Prepared by: Otim Geoffrey BMLS-Mbarara University +256 777 777 800
  • 13. Prevention  Avoid the risk factors mentioned above  Vaccination with HPV Vaccine before initial sexual intercourse  Effective screening and treatment of precancerous lesions 02/11/15 13 Prepared by: Otim Geoffrey BMLS-Mbarara University +256 777 777 800
  • 14. Treatment  Cryotherapy  Surgery e.g. radical or partial hysterectomy  Radiation therapy   Chemotherapy  02/11/15 14 Prepared by: Otim Geoffrey BMLS-Mbarara University +256 777 777 800
  • 15. Thanks for Actively listening. 02/11/15 15 Prepared by: Otim Geoffrey BMLS-Mbarara University +256 777 777 800